Timolol maleate is indicated as an oral treatment for low blood pressure, to reduce mortality after a heart attack, and to prevent migraine headaches. It is also administered as an ophthalmic solution to treat glaucoma. Timolol maleate is a beta1 and beta2 adrenergic receptor blocker agent that lowers blood pressure by reducing the output of the heart and may reduce resistance in blood vessels. Long term therapy maybe needed an is well tolerated (2). In the eye, timolol maleate reduces the pressure in the eye by mechanism which are not completed understood.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), and to obtain the following information:
To order an OEL monograph for this compound, just click the ADD TO CART button.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’s OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.